Natco Pharma Hit 52-Week High On Approval of Black Fungus Drug

On May 24, the share price of Natco Pharma increased by more than 20% after the Drug Controller General of India (DCGI) authorized five firms, including Natco Pharma. The approval is to begin the development of the antifungal drug Amphotericin B

from Latest Business News | Finance News India | International Share Market – Oneindia Money https://ift.tt/3ueOJhm